Search research articles
Contact Us
Filters
Showing results (221-230 of 229) with videos related to
Page
of 23
Sort By:
You have reached the last page of results.
This site can display upto 229 results.
Radiology
|
October 14, 1998
Gadolinium-enhanced excretory MR urography after low-dose diuretic injection: comparison with conventional excretory urography
C C Nolte-Ernsting, A Bücker, G B Adam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1995
Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma
J Atzpodien, E Lopez Hänninen, H Kirchner, et al.
Genes, Chromosomes & Cancer
|
February 1, 1993
Detection of somatic changes in human renal cell carcinomas with oligonucleotide probes specific for simple repeat motifs
S Bock, J T Epplen, H Noll-Puchta, et al.
Actas Urologicas Espanolas
|
March 13, 2010
[Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma]
A Stenzl, N C Cowan, M De Santis, et al.
International Journal of Oncology
|
June 16, 2001
Differential expression of the lung resistance-related protein/major vault protein in the histological compartments of nephroblastomas
T Efferth, M E Bode, H G Schulten, et al.
Anticancer Research
|
November 20, 2001
Differential expression of the heat shock protein 70 in the histological compartments of nephroblastomas
T Efferth, H G Schulten, P Thelen, et al.
International Journal of Oncology
|
July 11, 2001
Differential expression of the multidrug resistance-related protein MRP1 in the histological compartments of nephroblastomas
T Efferth, P Thelen, H G Schulten, et al.
American Journal of Clinical Oncology
|
June 17, 1998
Management of carcinoma of the bladder
Z Petrovich, L Baert, S D Boyd, et al.
Der Urologe. Ausg. A
|
September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]
J Lehmann, M Retz, G Steiner, et al.
Page
of 23
Search research articles
Search
Showing results (221-230 of 229) with videos related to
Sort By:
Page
of 23
You have reached the last page of results.
This site can display upto 229 results.
Radiology
|
October 14, 1998
Gadolinium-enhanced excretory MR urography after low-dose diuretic injection: comparison with conventional excretory urography
C C Nolte-Ernsting, A Bücker, G B Adam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1995
Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma
J Atzpodien, E Lopez Hänninen, H Kirchner, et al.
Genes, Chromosomes & Cancer
|
February 1, 1993
Detection of somatic changes in human renal cell carcinomas with oligonucleotide probes specific for simple repeat motifs
S Bock, J T Epplen, H Noll-Puchta, et al.
Actas Urologicas Espanolas
|
March 13, 2010
[Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma]
A Stenzl, N C Cowan, M De Santis, et al.
International Journal of Oncology
|
June 16, 2001
Differential expression of the lung resistance-related protein/major vault protein in the histological compartments of nephroblastomas
T Efferth, M E Bode, H G Schulten, et al.
Anticancer Research
|
November 20, 2001
Differential expression of the heat shock protein 70 in the histological compartments of nephroblastomas
T Efferth, H G Schulten, P Thelen, et al.
International Journal of Oncology
|
July 11, 2001
Differential expression of the multidrug resistance-related protein MRP1 in the histological compartments of nephroblastomas
T Efferth, P Thelen, H G Schulten, et al.
American Journal of Clinical Oncology
|
June 17, 1998
Management of carcinoma of the bladder
Z Petrovich, L Baert, S D Boyd, et al.
Der Urologe. Ausg. A
|
September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]
J Lehmann, M Retz, G Steiner, et al.
Page
of 23